Cortical and Subcortical Brain Morphometry Differences Between Patients With Autism Spectrum Disorder and Healthy Individuals Across the Lifespan / Daan van Rooij en The American Journal of Psychiatry, Año 2018 - Vol. 175 - No.4 (Abril)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2018 - Vol. 175 - No.4 (Abril) . - pp. 359-369 Título : Cortical and Subcortical Brain Morphometry Differences Between Patients With Autism Spectrum Disorder and Healthy Individuals Across the Lifespan : Results From the ENIGMA ASD Working Group Tipo de documento: texto impreso Autores: Daan van Rooij, Autor ; Evdokia Anagnostou, Autor ; Celso Arango, Autor Fecha de publicación: 2018 Artículo en la página: pp. 359-369 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Autismo, Morfología cerebral, ENIGMA, Esperanza de vida Resumen: Neuroimaging studies show structural differences in both cortical and subcortical brain regions in children and adults with autism spectrum disorder (ASD) compared with healthy subjects. Link: ./index.php?lvl=notice_display&id=13310 [artículo] Cortical and Subcortical Brain Morphometry Differences Between Patients With Autism Spectrum Disorder and Healthy Individuals Across the Lifespan : Results From the ENIGMA ASD Working Group [texto impreso] / Daan van Rooij, Autor ; Evdokia Anagnostou, Autor ; Celso Arango, Autor . - 2018 . - pp. 359-369. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2018 - Vol. 175 - No.4 (Abril) . - pp. 359-369 Palabras clave: Autismo, Morfología cerebral, ENIGMA, Esperanza de vida Resumen: Neuroimaging studies show structural differences in both cortical and subcortical brain regions in children and adults with autism spectrum disorder (ASD) compared with healthy subjects. Link: ./index.php?lvl=notice_display&id=13310

A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder / Benjamin L. Handen en Journal of the American Academy of Child & Adolescent Psychiatry, Año 2017 - Vol. 56 - No.10 ([18/12/2017])

Público ISBD [artículo]  inJournal of the American Academy of Child & Adolescent Psychiatry > Año 2017 - Vol. 56 - No.10 [18/12/2017] . - pp. 849-856 Título : A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder : Open-Label Extension Tipo de documento: texto impreso Autores: Benjamin L. Handen, Autor ; Evdokia Anagnostou, Autor ; Michael G. Aman, Autor Fecha de publicación: 2017 Artículo en la página: pp. 849-856 Idioma : Inglés (eng) Palabras clave: Metformina, Trastorno del Espectro Autista, Aumento de Peso, Medicación Antipsicótica. Resumen: A previous study reported on a 16-week placebo-controlled, randomized clinical trial (RCT) of metformin for weight stabilization in 61 children and adolescents 6 to 17 years old with autism spectrum disorder who were prescribed atypical antipsychotics. Link: ./index.php?lvl=notice_display&id=9717 [artículo] A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder : Open-Label Extension [texto impreso] / Benjamin L. Handen, Autor ; Evdokia Anagnostou, Autor ; Michael G. Aman, Autor . - 2017 . - pp. 849-856. Idioma : Inglés (eng) in Journal of the American Academy of Child & Adolescent Psychiatry > Año 2017 - Vol. 56 - No.10 [18/12/2017] . - pp. 849-856 Palabras clave: Metformina, Trastorno del Espectro Autista, Aumento de Peso, Medicación Antipsicótica. Resumen: A previous study reported on a 16-week placebo-controlled, randomized clinical trial (RCT) of metformin for weight stabilization in 61 children and adolescents 6 to 17 years old with autism spectrum disorder who were prescribed atypical antipsychotics. Link: ./index.php?lvl=notice_display&id=9717

---

1 (1 - 2 / 2)